BeOne Medicines (ONC) Receivables - Other (2017 - 2023)

BeOne Medicines (ONC) has 7 years of Receivables - Other data on file, last reported at $1.7 million in Q4 2023.

• On a quarterly basis, Receivables - Other fell 42.91% year-over-year to $1.7 million in Q4 2023; TTM through Dec 2023 was $1.7 million, a 42.91% decrease from a year earlier, with the FY2023 full-year figure at $1.7 million, down 42.91% from the prior year.
• Receivables - Other for Q4 2023 stood at $1.7 million, up from $1.6 million in the prior quarter.
• Over the last five years, Receivables - Other for ONC reached as high as $7.2 million in Q3 2021 and fell as low as $1.3 million in Q1 2023.
• Historically, Receivables - Other has averaged $3.8 million across 5 years, with a median of $3.4 million in 2019.
• Across the five-year window, Receivables - Other jumped 235.96% in 2020 and plunged 74.81% in 2023, its largest moves.
• Year by year, Receivables - Other stood at $1.7 million in 2019, then jumped by 283.93% to $6.6 million in 2020, then fell by 23.67% to $5.1 million in 2021, then tumbled by 39.85% to $3.0 million in 2022, then sank by 42.91% to $1.7 million in 2023.
• Per Business Quant data, the three most recent Receivables - Other figures were $1.7 million in Q4 2023, $1.6 million in Q3 2023, and $2.0 million in Q2 2023.